Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02039752 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Asan Multivessel Registry

Study acronym: ASAN MV
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 5 versions Re-verified since Jun 23, 2019, no change to tracked fieldsv8-v12
  2. Primary completion date: Dec 2024 to Jun 2030
    • Study completion date: Jun 2025 to Dec 2030
    • Eligibility criteria shortened, about 2 words
    v7
  3. 2 versions Re-verified since Jun 16, 2016, no change to tracked fieldsv5-v6
  4. Collaborators expanded, about 4 wordsv4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  6. Interventions: TREATMENT (Other) to Treatment (Other)
    • Secondary endpoints revised (8)
    • Site contact updated
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
Trial Details
NCT Number NCT02039752
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 25,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov